Literature DB >> 21702881

Illness-specific anxiety: implications for functioning and utilization of medical services in adolescents with inflammatory bowel disease.

Laura C Reigada1, Jean-Marie Bruzzese, Keith J Benkov, Joseph Levy, Amanda R Waxman, Eva Petkova, Carrie Masia Warner.   

Abstract

PURPOSE. Adolescents with inflammatory bowel disease (IBD) may be at heightened risk for developing anxiety and depression. This cross-sectional pilot study examined the relationship between anxiety and depression and health-related behaviors. METHODS. Thirty-six adolescents with diagnosed IBD, ages 12-17, and their parents were recruited from two pediatric gastroenterology medical centers. RESULTS. Clinical levels of anxiety (22%) and depressive symptoms (30%) were reported by patients. Regression analyses revealed that IBD-specific anxiety was significantly associated with greater utilization of medical services and worsened psychosocial functioning. PRACTICE IMPLICATIONS. Results provide preliminary support that IBD-specific anxiety may play an important role in disease management, yet concerns are rarely systematically assessed by health professionals.
© 2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21702881     DOI: 10.1111/j.1744-6155.2011.00292.x

Source DB:  PubMed          Journal:  J Spec Pediatr Nurs        ISSN: 1539-0136            Impact factor:   1.260


  16 in total

1.  Identifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes.

Authors:  Andrea Knight; Pamela Weiss; Knashawn Morales; Marsha Gerdes; Melissa Rearson; Michelle Vickery; Ron Keren
Journal:  J Pediatr       Date:  2015-08-25       Impact factor: 4.406

2.  Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.

Authors:  Mimi C Tan; Hashem B El-Serag; Jason K Hou
Journal:  Dig Dis Sci       Date:  2016-12-23       Impact factor: 3.199

3.  Transition of Care in Inflammatory Bowel Disease.

Authors:  Bincy P Abraham; Stacy A Kahn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

4.  Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.

Authors:  Marina Arvanitis; Darren A DeWalt; Christopher F Martin; Millie D Long; Wenli Chen; Beth Jaeger; Robert S Sandler; Michael D Kappelman
Journal:  J Pediatr       Date:  2016-05-02       Impact factor: 4.406

5.  Psychometric Evaluation of the PROMIS® Pediatric Psychological and Physical Stress Experiences Measures.

Authors:  Katherine B Bevans; William Gardner; Kathleen A Pajer; Brandon Becker; Adam Carle; Carole A Tucker; Christopher B Forrest
Journal:  J Pediatr Psychol       Date:  2018-07-01

Review 6.  Pediatric inflammatory bowel disease and depression: treatment implications.

Authors:  Divya Keethy; Christine Mrakotsky; Eva Szigethy
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

7.  Qualitative development of the PROMIS(R) pediatric stress response item banks.

Authors:  Katherine B Bevans; William Gardner; Kathleen Pajer; Anne W Riley; Christopher B Forrest
Journal:  J Pediatr Psychol       Date:  2012-11-03

8.  Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression.

Authors:  Divya Keerthy; Ada Youk; Arvind I Srinath; Nasuh Malas; Simona Bujoreanu; Athos Bousvaros; David Keljo; David R DeMaso; Eva M Szigethy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

9.  Mediated moderation of the relation between maternal and adolescent depressive symptoms: role of adolescent physical health.

Authors:  Mark A Ferro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-08-11       Impact factor: 4.328

10.  Predicting the development of psychological morbidity in inflammatory bowel disease: a systematic review.

Authors:  Anna B Hoogkamer; Alenka J Brooks; Georgina Rowse; Alan J Lobo
Journal:  Frontline Gastroenterol       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.